BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 23460744)

  • 1. Myeloid-derived suppressor cells regulate growth of multiple myeloma by inhibiting T cells in bone marrow.
    Ramachandran IR; Martner A; Pisklakova A; Condamine T; Chase T; Vogl T; Roth J; Gabrilovich D; Nefedova Y
    J Immunol; 2013 Apr; 190(7):3815-23. PubMed ID: 23460744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Runx2 Deficiency in Osteoblasts Promotes Myeloma Progression by Altering the Bone Microenvironment at New Bone Sites.
    Xu X; Zhang C; Trotter TN; Gowda PS; Lu Y; Ponnazhagan S; Javed A; Li J; Yang Y
    Cancer Res; 2020 Mar; 80(5):1036-1048. PubMed ID: 31911552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells.
    Wang J; De Veirman K; De Beule N; Maes K; De Bruyne E; Van Valckenborgh E; Vanderkerken K; Menu E
    Oncotarget; 2015 Dec; 6(41):43992-4004. PubMed ID: 26556857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid-derived suppressor cells in the development of lung cancer.
    Ortiz ML; Lu L; Ramachandran I; Gabrilovich DI
    Cancer Immunol Res; 2014 Jan; 2(1):50-8. PubMed ID: 24778162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells.
    Sinha P; Okoro C; Foell D; Freeze HH; Ostrand-Rosenberg S; Srikrishna G
    J Immunol; 2008 Oct; 181(7):4666-75. PubMed ID: 18802069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple myeloma induces Mcl-1 expression and survival of myeloid-derived suppressor cells.
    De Veirman K; Van Ginderachter JA; Lub S; De Beule N; Thielemans K; Bautmans I; Oyajobi BO; De Bruyne E; Menu E; Lemaire M; Van Riet I; Vanderkerken K; Van Valckenborgh E
    Oncotarget; 2015 Apr; 6(12):10532-47. PubMed ID: 25871384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo.
    Hegde VL; Singh UP; Nagarkatti PS; Nagarkatti M
    J Immunol; 2015 Jun; 194(11):5211-22. PubMed ID: 25917103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid derived suppressor cells are numerically, functionally and phenotypically different in patients with multiple myeloma.
    Favaloro J; Liyadipitiya T; Brown R; Yang S; Suen H; Woodland N; Nassif N; Hart D; Fromm P; Weatherburn C; Gibson J; Ho PJ; Joshua D
    Leuk Lymphoma; 2014 Dec; 55(12):2893-900. PubMed ID: 24625328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of Muc1-regulated beta-catenin stability results in aberrant expansion of CD11b+Gr1+ myeloid-derived suppressor cells from the bone marrow.
    Poh TW; Bradley JM; Mukherjee P; Gendler SJ
    Cancer Res; 2009 Apr; 69(8):3554-62. PubMed ID: 19351842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development.
    Greifenberg V; Ribechini E; Rössner S; Lutz MB
    Eur J Immunol; 2009 Oct; 39(10):2865-76. PubMed ID: 19637228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the therapeutic potential of bone marrow-derived myeloid suppressor cell (MDSC) adoptive transfer in mouse models of autoimmunity and allograft rejection.
    Drujont L; Carretero-Iglesia L; Bouchet-Delbos L; Beriou G; Merieau E; Hill M; Delneste Y; Cuturi MC; Louvet C
    PLoS One; 2014; 9(6):e100013. PubMed ID: 24927018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immature myeloid Gr-1+ CD11b+ cells from lipopolysaccharide-immunosuppressed mice acquire inhibitory activity in the bone marrow and migrate to lymph nodes to exert their suppressive function.
    Landoni VI; Martire-Greco D; Rodriguez-Rodrigues N; Chiarella P; Schierloh P; Isturiz MA; Fernández GC
    Clin Sci (Lond); 2016 Feb; 130(4):259-71. PubMed ID: 26582821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth.
    Porembka MR; Mitchem JB; Belt BA; Hsieh CS; Lee HM; Herndon J; Gillanders WE; Linehan DC; Goedegebuure P
    Cancer Immunol Immunother; 2012 Sep; 61(9):1373-85. PubMed ID: 22215137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclophosphamide-induced myeloid-derived suppressor cell population is immunosuppressive but not identical to myeloid-derived suppressor cells induced by growing TC-1 tumors.
    Mikyšková R; Indrová M; Polláková V; Bieblová J; Símová J; Reiniš M
    J Immunother; 2012 Jun; 35(5):374-84. PubMed ID: 22576342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor release.
    Jayaraman P; Parikh F; Lopez-Rivera E; Hailemichael Y; Clark A; Ma G; Cannan D; Ramacher M; Kato M; Overwijk WW; Chen SH; Umansky VY; Sikora AG
    J Immunol; 2012 Jun; 188(11):5365-76. PubMed ID: 22529296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-17A deficiency ameliorates streptozotocin-induced diabetes.
    Tong Z; Liu W; Yan H; Dong C
    Immunology; 2015 Oct; 146(2):339-46. PubMed ID: 26211676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of myelodysplasia by myeloid-derived suppressor cells.
    Chen X; Eksioglu EA; Zhou J; Zhang L; Djeu J; Fortenbery N; Epling-Burnette P; Van Bijnen S; Dolstra H; Cannon J; Youn JI; Donatelli SS; Qin D; De Witte T; Tao J; Wang H; Cheng P; Gabrilovich DI; List A; Wei S
    J Clin Invest; 2013 Nov; 123(11):4595-611. PubMed ID: 24216507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization of human Cd33+ and Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines.
    Lechner MG; Megiel C; Russell SM; Bingham B; Arger N; Woo T; Epstein AL
    J Transl Med; 2011 Jun; 9():90. PubMed ID: 21658270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor induced hepatic myeloid derived suppressor cells can cause moderate liver damage.
    Eggert T; Medina-Echeverz J; Kapanadze T; Kruhlak MJ; Korangy F; Greten TF
    PLoS One; 2014; 9(11):e112717. PubMed ID: 25401795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly (I: C) modulates the immunosuppressive activity of myeloid-derived suppressor cells in a murine model of breast cancer.
    Forghani P; Waller EK
    Breast Cancer Res Treat; 2015 Aug; 153(1):21-30. PubMed ID: 26208484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.